News
Eli Lilly's obesity and Type 2 diabetes drug, Mounjaro, has gained approval from the Indian drug control authority for its ...
A woman who lost six stone from taking Mounjaro has shared a bit of advice for how she managed to keep the weight off ...
Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
inews.co.uk on MSN2d
No Mounjaro, GPs tell patients, unless you hit four criteria – and you’re very luckyGPs and pharmacists have warned it will be impossible to meet soaring demand for weight-loss jabs following their rollout on ...
Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...
Zacks Investment Research on MSN6d
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Eli Lilly LLY -1.05% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback